Product Business Settings

Certara GlobalSubmit eCTD software is popular in Pharmaceuticals industry and is widely used by Enterprise.

Certara GlobalSubmit eCTD software Product Overview

Globalsubmit provides eCTD submission software to mitigate rejection risks in a complex regulatory environment. Differences in regulatory requirements complicate the submission process.

How satisfied the customers are with Certara GlobalSubmit eCTD software use-cases

Reviews

"...GlobalSubmits approach to document management is a familiar one intuitive interface, easy implementation that appeals to the novice user, built-in templates and workflows, and integration with eCTD publishing systems...." Peer review

Certara GlobalSubmit eCTD software Customer Insights, Testimonials and Case Studies

lightning

Peers used Certara GlobalSubmit eCTD software for sending & publishing communications and workflow management

Certara GlobalSubmit eCTD software Features

  • Low
  • Medium
  • High
FEATURE RATINGS AND REVIEWS
Custom Reports

4.34/5 ★

Read Reviews (48)
Analytics

3.26/5 ★

Read Reviews (1)
CAPABILITIES RATINGS AND REVIEWS
Custom Reports

4.34/5 ★

Read Reviews (48)
Analytics

3.26/5 ★

Read Reviews (1)

Software Failure Risk Guidance

?

for Certara GlobalSubmit eCTD software

Overall Risk Meter

Low Medium High

Top Failure Risks for Certara GlobalSubmit eCTD software

Certara, USA. News

Financial
 

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025 - The Manila Times

Certara will announce its fourth quarter and full year 2025 financial results on February 26, 2026, before the market opens. A conference call to discuss the results will follow at 8:30 AM ET.

Read more →
Financial
 

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025 - marketscreener.com

Certara, Inc. will announce its fourth quarter and full year 2025 financial results on February 26, 2026. The company will host a conference call to discuss these results, with a live and archived webcast available on its website.

Read more →
Executive
 

Certara, Inc. Appoints Jon Resnick as CEO, Succeeding William Feehery, Effective January 1, 2026 - Quiver Quantitative

Certara, Inc. has appointed Jon Resnick as CEO, effective January 1, 2026, succeeding William Feehery. Resnick, with over 20 years of experience at IQVIA, is expected to drive growth and innovation in drug development. Feehery will remain as an external advisor during the transition. The company reaffirms its 2025 financial outlook.

Read more →
Executive
 

Certara Appoints Jon Resnick as Chief Executive Officer - The Manila Times

Certara appointed Jon Resnick as CEO, effective January 1, 2026, succeeding William Feehery. Resnick, with over 20 years at IQVIA, brings extensive leadership experience in health sciences and business operations. Certara reaffirms its 2025 financial outlook and highlights its focus on advancing model-informed drug development.

Read more →

Certara, USA. Profile

Company Name

Certara, USA.

Company Website

https://www.certara.com/

HQ Location

123 South Broad Street, Suite 1850, Philadelphia, PA 19109, US

Employees

11-50

Social

Facebook Linkedin Twitter

Financials

PRIVATE